Trial reportAsian Pacific journal of cancer prevention : APJCP2025
Outcomes of Enhanced Recovery after Surgery (ERAS) in Gynaecologic Oncology: A Randomized Clinical Trial.
Trial report in Asian Pacific journal of cancer prevention : APJCP, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: ERAS protocols in major gynaecologic oncology surgery (MGOS), have established effectiveness in reducing complications, Length of Stay (LOS), and hospital costs. Their implementation appears to improve patient care compared to conventional perioperative practice. This study assessed the efficacy of ERAS protocol versus conventional postoperative care in the recovery of patients undergoing major gynaecological oncology surgery (MGOS). Methods: A prospective, randomized, single-centre study. A sample size of convenience included 101 patients with gynaecological cancer who underwent MGOS. Patients randomized into two groups: in group A (n=51, 50.5%), patients allocated to the ERAS protocol, and in group B (n=50, 49.5%), patients followed conventional care. Results: The mean age in group A was 52.8 years and in group B 56.7 years (p = 0.1). In the ERAS group the LOS was significantly lower compared to the control group, mean 3.9 versus 5.9 days (p < 0.001). All indicators of recovery, such as mobilisation, feeding, bowel motility , discontinuation of intravenous (IV) administration, catheter and drainage removal in the first 24 hours, were significantly improved in patients in the ERAS group. Furthermore complications in patients in the ERAS group, such as fever, urinary tract infection, and perioperative bleeding, were also significantly lower.Conclusion: Within the limitations of a small single centre RCT, ERAS protocol in MGOS appeared to promote early enteral feeding, discontinuation of IV fluids, early gastrointestinal motility , faster removal of drainage and bladder catheter, faster patient standing and mobilisation, fewer requirements for blood transfusion, lower rate of drowsiness and sedation and episodes postoperative fever and leukocytosis.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.